H-1B sponsorship profile: Amerisource Bergen Drug Corporation. Across U.S. Department of Labor LCA disclosures, Amerisource Bergen Drug Corporation filed 3 Labor Condition Applications covering 3 H-1B worker positions between fiscal year 2023 and fiscal year 2023. The employer’s DOL certification rate sits at 100% (3 certified of 3 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Amerisource Bergen Drug Corporation’s H-1B petitions range from $138,965 at the low end to $138,965 at the high end, with a petition-weighted average of $138,965. That range reflects the mix of occupations the company sponsors, led by Lead Data Engineer (3 petitions at $138,965 avg). H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Amerisource Bergen Drug Corporation is headquartered in Conshohocken, PA under NAICS code 424210, and places H-1B workers across 1 state, most heavily in SC. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Amerisource Bergen Drug Corporation ranks. By H-1B petition volume, Amerisource Bergen Drug Corporation is #37,433 of 119,880 employers nationally and #1,111 of 3,282 employers headquartered in PA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.